Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Interim Management Statement

12 May 2011 07:00

RNS Number : 4418G
Huntsworth PLC
12 May 2011
 



 

 

 

 

 

 

12 May 2011

 

 

Huntsworth plc

("Huntsworth" or "the Group")

Interim Management Statement 

 

Huntsworth Wins £15m of New Business

 

Huntsworth issues this Interim Management Statement to cover the period from 1 January 2011 to date.

 

Huntsworth, the public relations and healthcare communications Group, has won over £15m of new business since reporting full year results six weeks ago including a 27 country mandate for the European Union, a 17 country programme for DHL, and, the newly acquired Atomic, has been awarded the largest win in its history. As a result of these and other contract wins, committed revenues for the Group are now approximately 80% of 2011 full year forecasts on a strongly rising revenue stream.

 

As reported at the full year, management expects revenues to be heavily second half weighted as these large accounts come on stream, underpinning our revenue expectations for 2011 and giving added confidence in 2012 organic growth targets.

 

The balance sheet remains robust with net debt comfortably within banking covenants.

 

 

Grayling

 

Following the 38 country win of British Airways announced in March, Grayling has seen increased client interest in its international capabilities. DHL, the international carrier company, has appointed Grayling in 17 countries and the European Union has appointed Grayling to handle a three year, six million euro, 27 member state anti-smoking campaign and OMV, Central Europe's leading oil and gas supplier, has expanded its relationship into six countries.

 

Atomic has been awarded a seven figure fee account - the largest in its history - and has already made seven international pitches alongside their new Grayling colleagues.

 

 

Huntsworth Health

 

Huntsworth Health has been appointed by a top ten Pharma company to prepare for the launch of a novel new oncology product. Another top ten Pharma has added Huntsworth to its preferred supplier lists for global assignments in both medical education and medical communications. In addition Huntsworth Health was invited to participate as a member of a new independent network to pitch for 13 individual therapeutic categories at a top ten pharma.

  

 

Citigate

 

Citigate continues to build on its position as a leading M&A advisory consultancy and was recently ranked 5th globally by volume in the mergermarket league table. Current projects in the UK include transaction work for the London Stock Exchange, the Yorkshire Building Society and Chaucer Holdings. Internationally Citigate has won a number of new accounts, including the Malaysian Smelting Company and the state of Ontario, Canada in support of its international investment and trade programmes in China.

 

 

Red

 

RED has 90% of its 2011 budget committed and has added more blue chip names to its UK client list - including 20th Century Fox, Schweppes Abbey Well and Gatwick Airport.

 

 

 

Peter Chadlington, Huntsworth CEO, commented "As a direct result of the reorganisation of the Group, we are beginning to see real momentum throughout the Group as the number of global and international opportunities increase significantly. We are confident that we will meet management expectations for 2011 and believe that we are now on course for good organic growth in 2012."

  

 

 

 

Enquiries to:

 

Huntsworth PLC +44 (0)207 224 8778

Peter Chadlington, Chief Executive

Colin Adams, Group Finance Director

 

Citigate Dewe Rogerson +44 (0)20 7638 9571

Simon Rigby

Angharad Couch

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDKDDQKBKBCPD
Date   Source Headline
26th Jul 20177:00 amRNSInterim Results for the six months to 30 June 2017
11th Jul 20172:28 pmRNSHolding(s) in Company
6th Jul 20172:04 pmRNSDirector/PDMR Shareholding
5th Jul 20177:00 amRNSAdditional Listing
4th Jul 20173:33 pmRNSHolding(s) in Company
3rd Jul 20177:00 amRNSAcquisition of The Creative Engagement Group
29th Jun 20175:53 pmRNSHolding(s) in Company
29th Jun 201712:33 pmRNSDisposal by BlueFocus
22nd Jun 20179:00 amRNSNotice of Interim Results
14th Jun 201711:27 amRNSHolding(s) in Company
2nd Jun 201711:07 amRNSScrip Dividend Alternative
25th May 20172:22 pmRNSResults of Annual General Meeting
25th May 20177:00 amRNSTrading Update
9th May 20175:38 pmRNSHolding(s) in Company
9th May 20179:13 amRNSDirector Declaration
5th May 20174:40 pmRNSSecond Price Monitoring Extn
5th May 20174:35 pmRNSPrice Monitoring Extension
28th Apr 20174:47 pmRNSHolding(s) in Company
28th Apr 201710:48 amRNSHolding(s) in Company
27th Apr 20178:59 amRNSDisposal and lock-up arrangement
25th Apr 20179:30 amRNSNotice of AGM
22nd Mar 201710:30 amRNSDirector/PDMR Shareholding
21st Mar 20177:00 amRNSPreliminary results year ended 31 December 2016
16th Feb 20177:00 amRNSTrading update for year ending 31 December 2016
3rd Feb 20173:27 pmRNSHolding(s) in Company
27th Jan 20174:08 pmRNSNotice of Result & Change to Audit Committee Chair
16th Dec 20164:49 pmRNSDirector/PDMR Shareholding
16th Dec 20163:27 pmRNSHolding(s) in Company
16th Dec 20162:18 pmRNSChange of Auditor
14th Dec 20164:00 pmRNSDirector/PDMR Shareholding
13th Dec 201611:15 amRNSDirector/PDMR Shareholding
9th Dec 20165:10 pmRNSDirector/PDMR Shareholding
6th Dec 20164:21 pmRNSChange of Auditor
6th Dec 20168:18 amRNSHolding(s) in Company
2nd Dec 201612:59 pmRNSBlock listing Interim Review
1st Dec 20161:05 pmRNSTotal Voting Rights
10th Nov 20164:17 pmRNSDirector/PDMR Shareholding
9th Nov 20164:10 pmRNSDirector/PDMR Shareholding
3rd Nov 201610:42 amRNSAdditional Listing
6th Oct 20162:45 pmRNSScrip Dividend Alternative
15th Sep 20162:22 pmRNSHolding(s) in Company
12th Sep 20164:17 pmRNSDirector/PDMR Shareholding
4th Aug 20165:45 pmRNSHolding(s) in Company
4th Aug 201611:28 amRNSHolding(s) in Company
3rd Aug 20164:43 pmRNSHolding(s) in Company
3rd Aug 20162:19 pmRNSHolding(s) in Company
3rd Aug 20162:10 pmRNSHolding(s) in Company
2nd Aug 20167:00 amRNSTotal Voting Rights
26th Jul 20166:00 pmRNSDirector/PDMR Shareholding
26th Jul 20167:00 amRNSInterim results for the six months to 30 June 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.